Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Adjust your budget when income, expenses, or goals change, ensuring your plan remains aligned with long-term financial health.
22,393 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
For the first time ever, Citi Wealth notes a surge in ultrawealthy U.S. clients seeking cross-border diversification ...
Adobe has pulled back about 40% from its peak, but new AI-driven products and expanding ARR are reinvigorating the bu...
A $1,000 invest? here’s what XRP and Bitcoin could be worth by 2027, depending on regulatory outcomes for XRP and mac...
The House advances a sweeping housing bill described as the first major housing since the 1990s, signaling a national...
A disciplined, six‑stock dividend plan could turn $100,000 into reliable annual income. Here's the latest layout, yie...
Cisco stock is at a pivotal crossroads as AI infrastructure demand accelerates. This article weighs targets, catalyst...
World Cup fever meets a new kind of betting on Kalshi’s prediction-market platform. The company says it’s not a sport...
Roundhill unveiled plans for a suite of ETFs that would track prediction-market odds on the 2028 U.S. election, signa...
From a brutal 1995 fundraising sprint to a $2+ trillion market cap today, Amazon's origin story centers on relentless...
RE/MAX reports a rise in 2025 net income to $8.2 million, driven by growth outside the U.S. even as U.S. agent counts...
A seismic shift is unfolding in housing finance: the rental market entered infrastructure era, pushing lenders to red...